Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sandro Pasquali

Showing results (1-10 of 106) with videos related to

Pageof 11
Sort By:
Therapeutic Advances in Medical Oncology|June 14, 2017
Neoadjuvant chemotherapy in soft tissue sarcomas: latest evidence and clinical implicationsSandro Pasquali, Alessandro Gronchi
Cancer Treatment Reviews|July 16, 2014
Contemporary controversies and perspectives in the staging and treatment of patients with lymph node metastasis from melanoma, especially with regards positive sentinel lymph node biopsySandro Pasquali, Andrew Spillane
The Cochrane Database of Systematic Reviews|April 28, 2015
Diagnostic accuracy of endoscopic ultrasonography (EUS) for the preoperative locoregional staging of primary gastric cancerSimone Mocellin, Sandro Pasquali
The Cochrane Database of Systematic Reviews|April 30, 2019
Risk-reducing medications for primary breast cancer: a network meta-analysisSimone Mocellin, Annabel Goodwin, Sandro Pasquali
The Cochrane Database of Systematic Reviews|July 10, 2009
Fluoropyrimidine-HAI (hepatic arterial infusion) versus systemic chemotherapy (SCT) for unresectable liver metastases from colorectal cancerSimone Mocellin, Sandro Pasquali, Donato Nitti
Annals of Surgery|December 22, 2010
The impact of surgery on survival of patients with cutaneous melanoma: revisiting the role of primary tumor excision marginsSimone Mocellin, Sandro Pasquali, Donato Nitti
Mini Reviews in Medicinal Chemistry|January 20, 2009
Oncomirs: from tumor biology to molecularly targeted anticancer strategiesSimone Mocellin, Sandro Pasquali, Pierluigi Pilati
Frontiers in Oncology|September 19, 2022
Beyond targeting amplified MDM2 and CDK4 in well differentiated and dedifferentiated liposarcomas: From promise and clinical applications towards identification of progression driversGiuliana Cassinelli, Sandro Pasquali, Cinzia Lanzi
Annals of Surgical Oncology|December 15, 2010
A pilot study reporting outcomes for melanoma patients of a minimal access ilio-inguinal dissection technique based on two incisionsAndrew John Spillane, Monica Tucker, Sandro Pasquali
Biochemical Pharmacology|August 4, 2023
Targeting EZH2 in SMARCB1-deficient sarcomas: Advances and opportunities to potentiate the efficacy of EZH2 inhibitorsCinzia Lanzi, Noemi Arrighetti, Sandro Pasquali, et al.
Pageof 11

Showing results (1-10 of 106) with videos related to

Sort By:
Pageof 11
Therapeutic Advances in Medical Oncology|June 14, 2017
Neoadjuvant chemotherapy in soft tissue sarcomas: latest evidence and clinical implicationsSandro Pasquali, Alessandro Gronchi
Cancer Treatment Reviews|July 16, 2014
Contemporary controversies and perspectives in the staging and treatment of patients with lymph node metastasis from melanoma, especially with regards positive sentinel lymph node biopsySandro Pasquali, Andrew Spillane
The Cochrane Database of Systematic Reviews|April 28, 2015
Diagnostic accuracy of endoscopic ultrasonography (EUS) for the preoperative locoregional staging of primary gastric cancerSimone Mocellin, Sandro Pasquali
The Cochrane Database of Systematic Reviews|April 30, 2019
Risk-reducing medications for primary breast cancer: a network meta-analysisSimone Mocellin, Annabel Goodwin, Sandro Pasquali
The Cochrane Database of Systematic Reviews|July 10, 2009
Fluoropyrimidine-HAI (hepatic arterial infusion) versus systemic chemotherapy (SCT) for unresectable liver metastases from colorectal cancerSimone Mocellin, Sandro Pasquali, Donato Nitti
Annals of Surgery|December 22, 2010
The impact of surgery on survival of patients with cutaneous melanoma: revisiting the role of primary tumor excision marginsSimone Mocellin, Sandro Pasquali, Donato Nitti
Mini Reviews in Medicinal Chemistry|January 20, 2009
Oncomirs: from tumor biology to molecularly targeted anticancer strategiesSimone Mocellin, Sandro Pasquali, Pierluigi Pilati
Frontiers in Oncology|September 19, 2022
Beyond targeting amplified MDM2 and CDK4 in well differentiated and dedifferentiated liposarcomas: From promise and clinical applications towards identification of progression driversGiuliana Cassinelli, Sandro Pasquali, Cinzia Lanzi
Annals of Surgical Oncology|December 15, 2010
A pilot study reporting outcomes for melanoma patients of a minimal access ilio-inguinal dissection technique based on two incisionsAndrew John Spillane, Monica Tucker, Sandro Pasquali
Biochemical Pharmacology|August 4, 2023
Targeting EZH2 in SMARCB1-deficient sarcomas: Advances and opportunities to potentiate the efficacy of EZH2 inhibitorsCinzia Lanzi, Noemi Arrighetti, Sandro Pasquali, et al.
Pageof 11